<DOC>
	<DOCNO>NCT00204373</DOCNO>
	<brief_summary>The purpose study study safety efficacy high dose Prevacid long-term treatment patient secrete abnormally large amount gastric acid .</brief_summary>
	<brief_title>Treatment Zollinger-Ellison Syndrome With Prevacid</brief_title>
	<detailed_description>The aim protocol study medical management acid hypersecretory state include Zollinger-Ellison use Prevacid . The immediate objective heal peptic ulcer eliminate symptom long term prevent relapse symptom , lesion complication . Other objective include observation efficacy control gastric acid production safety high dose , long-term use Prevacid .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Endocrine Gland Neoplasms</mesh_term>
	<mesh_term>Multiple Endocrine Neoplasia</mesh_term>
	<mesh_term>Zollinger-Ellison Syndrome</mesh_term>
	<mesh_term>Gastrinoma</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<criteria>Diagnosed ZollingerEllison syndrome Pregnant lactating female</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>